Table 7. Urinary analysis data of the subjects (safety set).
| Placebo Group (n = 63)1 | Bio-Germanium Group (n = 66) | ||||
|---|---|---|---|---|---|
| Normal Results | Abnormal Findings | Normal Results | Abnormal Findings | P | |
| Specific Gravity n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| pH n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Protein n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Glucose n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Ketone n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Bilirubin n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Urobilinogen n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Nitrite n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Leukocyte n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
| Erythrocyte n, (%) | 63 (100.0) | 0 (0.0) | 66 (100.0) | 0 (0.0) | - |
The data represent results at follow-up.
1 Safety set analysis of the placebo group at follow-up consisted of 63 participants, excluding one subject’s voluntary dropout.
- Not applicable.